Balanced news tone
News Sentiment
FEMY sentiment intelligence
Femasys Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
84/100 classification confidence.
directly relevant articles
high-authority source matches
-4.3% over one week, -4.5% over four weeks, trend inactive, and below fair value.
Femasys Inc. (FEMY) Slips 4% After Recent Rally; Key Support Tested - Low Volatility Picks
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 May 2026 07:00
- Source
- GlobeNewswire
Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 May 2026 13:00
- Source
- GlobeNewswire
Femasys pushes fertility treatment into OB/GYN offices with first paid use
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 May 2026 07:00
- Source
- Stock Titan
Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Apr 2026 13:00
- Source
- GlobeNewswire
Femasys aims to bring first-line fertility treatment into OB/GYN offices
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Apr 2026 07:00
- Source
- Stock Titan
Medtech veteran joins Femasys to scale fertility, birth control products
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Apr 2026 07:00
- Source
- Stock Titan
Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 31 Mar 2026 07:00
- Source
- GlobeNewswire
Femasys Receives Nasdaq Extension to Regain Listing Compliance
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jan 2026 08:00
- Source
- The Globe and Mail
Femasys granted 180-day extension by Nasdaq to meet minimum bid price rule
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jan 2026 08:00
- Source
- Investing.com
Femasys Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jan 2026 08:00
- Source
- Market source
Femasys Stock Drop Looks Sharp, But How Deep Can It Go?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Dec 2025 08:00
- Source
- Trefis
PMCB Stock Jumps 25% After Company Sells Stake In Femasys
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 25 Nov 2025 08:00
- Source
- Stocktwits
Femasys Secures FDA Approval to Advance Final FemBloc®
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 03 Nov 2025 08:00
- Source
- GlobeNewswire
FEMASYS (FEMY) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Apr 2025 23:56
- Source
- Stock Titan
Femasys (NASDAQ: FEMY) down 50% - Well, that little rally died quickly then
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Oct 2023 07:00
- Source
- Dhaka Tribune